glp-1 vs glp-1ra Cardiovascular and mortality outcomes with receptor agonists other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia Agonistas receptor GLP-1

Bimagrumab Impresses at ADA: 100% of Weight Loss Attributed to Fat Reduction Bimagrumab is an activin type II receptor (ActRII) antagonist that promotes muscle synthesis by blocking muscle growth-inhibiting signals such as activin A and GDF11

Ritual Magnesium+ Multivitamins for Nutrient Gaps A multivitamin is a helpful way to fill nutrient gaps when your appetite is suppressed and youre not yet eating a truly balanced diet

Effect of natural polyphenols on breast cancer chemoprevention and treatment

Long-Term Strategy

Findings presented at the SCAI 2026 Scientific Sessions & CAIC-ACCI Summit in Montreal in April indicate that GLP-1 medications containing tirzepatide (Mounjaro and Zepbound) may help lower the risk of heart problems in people with obesity undergoing certain heart procedures